强化降压对溶栓后急性缺血性卒中脑肿胀的影响:ENCHANTED研究结果
ENCHANTED试验的二次分析纳入1477例溶栓的急性缺血性卒中患者,比较强化降压(收缩压目标130-140 mmHg)与指南推荐降压(收缩压<180 mmHg)对脑肿胀的影响。结果显示两组任何脑肿胀发生率无显著差异(22.12% vs 22.39%,调整OR 1.05,95%CI 0.81-1.36;P=0.71)。结论提示早期适度强化降压似乎不改变溶栓患者的脑肿胀。
要点
- 强化降压组与指南推荐组任何脑肿胀发生率无显著差异。
- 两组24小时平均收缩压差为6.6 mmHg。
- 不同肿胀严重程度分组结果一致。
核心结论
- 早期适度强化降压似乎不改变溶栓的急性缺血性卒中患者的脑肿胀。
研究设计与样本
- ENCHANTED试验的二次分析,该试验为部分析因、国际、多中心、开放标签、盲法终点、随机对照试验,评估阿替普酶剂量和血压控制水平。
- 共1477/2196(67.3%)例患者有连续脑影像(基线和随访CT或MRI),由对临床信息不知情的专家读者使用Apollo MIStar软件集中分析。
- 患者随机接受强化降压(1小时内收缩压目标130-140 mmHg,维持72小时)或指南推荐降压(收缩压目标<180 mmHg)。
主要发现
- 两组24小时内平均收缩压差为6.6 mmHg。
- 强化降压组与指南推荐组任何脑肿胀(评分1-6)发生率分别为22.12% vs 22.39%,调整OR 1.05(95%CI 0.81-1.36),P=0.71,无显著差异。
- 在不同肿胀严重程度分组(评分2-6、3-6、4-6)及肿胀评分的序数移位上,结果一致。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cerebral swelling in relation to cytotoxic edema is a predictor of poor outcome in acute ischemic stroke (AIS) and elevated blood pressure (BP) promotes its development. Whether intensive BP-lowering treatment reduces cerebral swelling is uncertain. We aimed to determine whether intensive BP lowering reduces the severity of cerebral swelling after thrombolysis for AIS. METHODS: A secondary analysis of the ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study), a partial factorial, international, multicenter, open-label, blinded end point, randomized controlled trial of alteplase dose and levels of BP control in thrombolyzed patients with AIS. Participants were randomly assigned to intensive (systolic target 130-140 mm Hg within 1 hour; maintained for 72 hours) or guideline-recommended (systolic target <180 mm Hg) BP management. Available serial brain images (baseline and follow-up, computed tomography, or magnetic resonance imaging) were centrally analyzed with standardized techniques (Apollo MIStar software) by expert readers blind to clinical details to rate swelling severity (from 0 no to 6 most severe swelling [midline shift and effacement of basal cisterns]) and other abnormalities. Primary outcome was any cerebral swelling (score, 1-6) in logistic regression models. RESULTS: Of 1477/2196 (67.3%) patients (mean age, 67.7 years; female, 39.6%) with sequential scans, the between-group mean systolic BP difference was 6.6 mm Hg over 24 hours. No significant difference was found in the treatment effect on any cerebral swelling between intensive and guideline-recommended BP management (22.12% versus 22.39%, adjusted odds ratio, 1.05 [95% CI, 0.81-1.36]; P=0.71). Results were consistent across different groups of swelling severity (swelling score 2-6, 3-6, and 4-6; and ordinal shift on swelling score). CONCLUSIONS: Modest early intensive BP lowering does not seem to alter cerebral swelling in thrombolyzed patients with AIS. Further research is needed to quantify brain edema to allow a better understanding of the complex relations of BP and outcomes from AIS. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT01422616.
引用
- Zhang G, Chen C, Ren X, et al. Effects of Intensive Blood Pressure Lowering on Brain Swelling in Thrombolyzed Acute Ischemic Stroke: The ENCHANTED Results. Stroke. 2025. PMID: 40177745. doi:10.1161/STROKEAHA.124.049938
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。